Russia rolls out COVID-19 vaccine in Moscow


Russia launched its nationwide coronavirus immunization effort Saturday in Moscow, where thousands of workers in the city's health, education, and social services systems have signed up to receive the Sputnik V COVID-19 vaccine at 70 vaccinations facilities throughout the capital.
Those eligible for the inoculation at this stage include people in the aforementioned professions between 18 and 60 years old. People who have had respiratory illnesses within the last two weeks, those with chronic illnesses, and pregnant and breastfeeding women cannot receive a shot. Producers are only expected to make 2 million doses of the vaccine by the end of the year, so the Moscow rollout is considered a preliminary step.
The two-shot vaccine has been the subject of international scrutiny since it was registered in Russia while still undergoing mass testing, but developers say it causes no serious side effects and is more than 90 percent effective, a rate similar to Moderna's and Pfizer's vaccine candidates. The Russian government says that more than 100,000 people have already received the vaccine, including top officials and military personnel.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
BBC reports several of the people who went to clinics to get vaccinated Saturday were calm despite the outstanding questions, including one doctor who said her experience treating COVID-19 patients informed her decision to take her chances with the vaccine instead. Read more at The Associated Press and BBC.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The financial changes to expect in 'Awful April'
The Explainer As the new financial year begins, it brings changes for bills, wages and tax
By Marc Shoffman, The Week UK Published
-
Crossword: April 2, 2025
The Week's daily crossword
By The Week Staff Published
-
Sudoku medium: April 2, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published